CALISTA VINYARD: Open Payments
NPI 1124589197 · REDDING, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$123 in 6 payments from 6 companies in 2025. Trend: 2023 $93 · 2024 $390 · 2025 $123
Food & beverage: $123
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| ABBVIE INC. | 1 | $23 |
| Indivior Inc. | 1 | $21 |
| Braeburn Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $17 |
| Janssen Pharmaceuticals, Inc | 1 | $14 |
Products named: REXULTI, VRAYLAR, SUBLOCADE, BRIXADI, MOUNJARO, INVEGA SUSTENNA.
Industry payments across CA — which companies pay providers there.
